Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for August 2008
August 1, 2008
- ImClone Systems Issues Statement
- Senate, House Introduce Academic Detailing Bill to Provide Unbiased Drug Information to Doctors
- Senate, House Members Introduce Bill to Provide Doctors With Unbiased Information About Prescription Drugs
- Exercise in a Pill
August 4, 2008
- Clopidogrel Cleared for Marketing in Germany – Higher Administrative Court in Münster Backs the Immediate Execution of Approval
- Verispan: Merck Advances to No. 1 with Managed Care Executives
- inVentiv Health to Acquire Patient Marketing Group
- ImClone Systems Issues Statement
August 5, 2008
- FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees
- Pharmacopeia Announces Further Reductions to Workforce
- Psychiatrists Shift Away From Providing Psychotherapy
- MDRNA, Inc. Announces Second Quarter 2008 Financial Results and Additional Corporate Restructuring
- Valens Pharma Announces Next Steps
August 6, 2008
- MedicinesRegulator Gives Go-Ahead For First Ever Oral Antibiotic to Be Made Available Without Prescription to Treat Chlamydia
- Lilly Sells its Greenfield, Indiana, Operations to Covance; Expands Existing Collaboration Between the Two Companies
- Actavis Gets Go-Ahead for First Ever Oral Antibiotic Without Prescription in the UK – Clamelle to treat Chlamydia
- UK Physicians Fear New Revalidation Procedures Will Reduce Morale, Decrease Time with Patients and Belittle GP Professionalism, According to New TNS Healthcare Research
- Covance and Lilly Enter Into a Strategic R&D Collaboration
- Publicis Groupe to Acquire Performics Search Marketing Business
August 7, 2008
- GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
- King Pharmaceuticals Reports Second-Quarter 2008 Financial Results
- New Podcast Series from Abbott for People Living with Crohn's Disease
- Spiriva, Micardis and Flomax - Boehringer Ingelheim`s Highly Successful Products Show Good Growth
- Novartis Begins Shipment to US of Fluvirin Influenza Virus Vaccine With Three New Strains for the 2008-2009 Influenza Season
- Bayer Acquires Preclinical Anti-Cancer Program From Nycomed
August 8, 2008
- SEC Settles Civil Injunctive Action Against Former Executive of Massachusetts Public Company
- Gov. Patrick Should Veto the 'Pharmaceutical and Medical Device Manufacturer Conduct' Provision in S. 2863
- i3 Statprobe Selected to Assume Bulk of Lilly's U.S. Data Management Work
August 10, 2008
- FDA MedWatch - Simvastatin Used With Amiodarone - Risk of Rhabdomyolysis When Simvastatin is Used With Amiodarone
- Enrollment in Phase IIb Clinical Trial for I-vation TA (MK-0140) Suspended Pending Review of Study Design by Merck & Co., Inc.
August 11, 2008
August 12, 2008
- Schering-Plough Expands Its Presence in China, Enters Next Stage of Development
- Proton Pump Inhibitors Increase Risk of Bone Fractures
- Lipid Sciences Engages Rodman & Renshaw to Explore Strategic Options
August 13, 2008
- Prime Therapeutics Releases Annual Drug Trend Insights Report
- Talecris Enters into Definitive Merger Agreement with CSL
- Genentech Special Committee of Independent Directors Responds to Roche Proposal
- Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
- European Medicines Agency Update on Progressive Multifocal Leukoencephalopathy (PML) and Tysabri
August 14, 2008
August 15, 2008
- Meda Acquires Product Portfolio from Roche
- Cytos Biotechnology and Pfizer Enter Into a Research, Option and License Agreement for Certain Novel Vaccines for a Defined Number of Human Diseases
August 18, 2008
- Nycomed: Moving Ahead – Strong Results in Second Quarter 2008
- SymBio Pharmaceuticals and Eisai Sign License Agreement for bendamustine hydrochloride (SyB L-0501)
- Forbes Medi-Tech Announces Sale of Pharmaceutical Assets
- FDA Updates the Information for Healthcare Professionals Sheet for Byetta (exenatide)
August 19, 2008
- Video: Asmanex Twisthaler 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
- Tadalafil Shows Promise for Relief of Lower Urinary Tract Symptoms Associated With BPH
August 20, 2008
- Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma
- Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
- Lilly Announces Completion of SGX Acquisition
August 21, 2008
- Vidaza Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS
- FDA Requires Additional Information on Doribax for Treatment of Hospital-Acquired Pneumonia
- Segal Survey Predicts Continued Declines in All Trends -- Rx Trend Drops to Single Digits
August 22, 2008
- FDA Issues Early Communication About Ongoing Safety Review of Vytorin, Zocor and Zetia
- King Proposes Acquisition of Alpharma for $33 Per Share in Cash
- Proteome Systems Strengthens Focus on Diagnostics and Exits Therapeutics Business
- Economic Conditions Forcing Marketers To Reduce Advertising Budgets, According To ANA Survey
August 25, 2008
- FDA Approves Aloxi (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
- PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
- Patients Taking Cymbalta Experienced Reduced Chronic Low Back Pain in New Study
- Noven Provides Update on Daytrana Methylphenidate Transdermal System
- PDX Partners With Google Health to Make Prescription Data Available to Patients
- Manhattan Research Announces Top 10 Product Sites Visited by Physicians
- FDA Updates the Information for Healthcare Professionals Sheet for Tysabri (natalizumab)
August 26, 2008
- AHF Blasts GlaxoSmithKline Print Ads That Promote Fear of HIV Treatment
- Stanford Medical School Severely Restricts Industry Funding of Continuing Education for Physicians
August 27, 2008
- Tel-Aviv Court Rules in Favor of Sun Pharmaceutical; No Special Tender Offer Necessary in Taro Offer
- Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
- Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for Byetta
- Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer
- NICE Final Guidance Recommends Lucentis As Cost-Effective Treatment for Wet AMD
